Document is current
Any future updates will be listed below
-
Authors
Zaitsev, Alexey V.
Sreedevi, Karthi
Goode, Brianna
Warren, Junco S.
-
Funding
Funding for this research was provided by:
American Heart Association (24POST1186520)
College of Agriculture and Life Sciences, Virginia Polytechnic Institute and State University (Virginia Tech Research and Innovation Postdoctoral Scholarship)
National Institutes of Health (R01HL156667)
Virginia Polytechnic Institute and State University (FBRI Virginia Tech Carilion Operation Fund)
Seale Innovation Fund
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 21 January 2026
First Online: 7 February 2026
Declarations
:
: J.S.W, A.V.Z, and K.S. are co-founders of a startup company Vectorial Corp. created for the purpose of translation of AAV-PERM1 vector therapy into clinical practice.
